Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study

Sune F Nielsen1, Stig E Bojesen, Peter Schnohr

  • 1Department of Clinical Biochemistry, 54M1, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730 Herlev, Denmark.

BMJ (Clinical Research Ed.)
|September 8, 2012
PubMed

Insights

Elevated rheumatoid factor (RF) levels significantly increase the long-term risk of developing rheumatoid arthritis. Testing for RF may aid in early detection and referral for rheumatoid arthritis.

Area of Science:

  • Rheumatology
  • Immunology
  • Epidemiology

Background:

  • Rheumatoid factor (RF) is an autoantibody often found in patients with rheumatoid arthritis.
  • The predictive value of elevated RF levels for the long-term development of rheumatoid arthritis in the general population requires further investigation.

Purpose of the Study:

  • To determine if elevated plasma IgM rheumatoid factor (RF) concentrations are associated with the long-term development of rheumatoid arthritis (RA).

Main Methods:

  • A prospective cohort study involving 9712 white Danish individuals from the general population was conducted.
  • Participants were followed for up to 29 years, with baseline plasma RF levels categorized.
  • Rheumatoid arthritis development was assessed based on baseline RF levels.

Main Results:

  • A doubling in RF levels was associated with a 3.3-fold increased risk of developing RA.
  • The cumulative incidence of RA increased significantly with higher RF categories (P<0.0001).
  • Individuals with RF levels >100 IU/mL had a 26-fold increased risk of RA, with a 32% 10-year absolute risk in specific subgroups.

Conclusions:

  • Elevated RF levels in the general population are strongly associated with a significantly increased long-term risk of developing RA.
  • These findings suggest that RF testing could be a valuable tool for identifying individuals at high risk for RA.
  • The results may inform revised guidelines for early rheumatologist referral and the establishment of early arthritis clinics.
Abstract

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...